FEATURE ARTICLES

One of Europe’s leading medical diagnostics service providers has launched a ground-breaking new veterinary pathology solution that is set to revolutionise pet care across the UK, the Nordic countries and Europe, as two examples of its use illustrate

Thermo Fisher Scientific and software provider ChromSword recently collaborated to launch an automated high-performance liquid chromatography and ultrahigh-performance liquid chromatography method development system.

Following specific coverage of the 2022 Biomedical Science Congress in previous issues of Pathology in Practice, this month the magazine looks at plenary aspects and some of those delivering the education, training and management programmes.

Recently, Mark Reed canvassed many of his colleagues for their views on how the industry is perceived generally, and what they believe the future holds for the commercial diagnostics sector.

Pernicious anaemia is a common cause of vitamin B12 deficiency. Irrespective of the cause of the disease, the most well-defined consequence is disturbed blood cell production and resulting megaloblastic anaemia.

Effective cleaning and disinfection protocols are vital to minimise the risk of cross-infection in hospitals. Kayleigh Cox-Nowak provides an insight into effective protocols to reduce the risk of transmission of healthcare-associated infections.

Tony Cambridge provides a brief overview of the development of POCT and his evolving role in this near-patient service, and introduces a new website, including interactive media, devoted to all aspects of rapid and decentralised diagnostics.

Christopher Reilly-Stitt reports on two UK NEQAS BC webinars held in April and July, and the response received from an international online audience.

The development of new nucleic acid amplification techniques is bringing molecular diagnostics closer to the patient for faster results and improved patient management. A prime example of this latest near-patient capability is LAMP technology.

Vaccine-induced immune thrombocytopenia and thrombosis has been identified as a rare side effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. Alex Stephenson-Brown explains how an ELISA from Stago can detect cases of the condition.

The SARS-CoV-2 pandemic has brought many challenges that have driven the need to manage patients differently. Amanda Appleton and Emma Isom explain how the increased use of novel diagnostic solutions has helped to address issues in gastroenterology.

For over 50 years Sysmex has innovated and revolutionised the fields of haematology, haemostasis and urinalysis. Here, the company revisits some of the key landmarks in the history of Sysmex and how they have helped shape today's laboratories.

An overview of the role of stable isotope analysis and the benefits the technology has to offer to the forensic pathologist.

A brief preview of the upcoming Biomedical Science Congress event focusing on some of the speakers on the scientific programme.

Victoria Tuckley summarises the 2020 Annual Report. Here, she also highlights how lessons can be learned about communication and robust planning for future emergency situations where the environment is continuously evolving.

This month’s cover story looks at vaccine-induced thrombocytopenia and thrombosis (VITT), a rare side-effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. The following examples of open-access current research expand on this theme.

Testing is fundamental to identify and prevent the spread of SARS-CoV-2, but how can laboratories access automation technologies to respond to increased demand? Penny Pinnock explores how smart finance can help laboratories enhance testing capacity.

Laboratories across the world use cytocentrifugation to present cells for microscopic analysis while maintaining their morphology. Here, Epredia gives a brief history of the Cytospin and the use of cytology samples to detect respiratory viruses.

South Korea’s response to the pandemic has been widely praised, achieving success through rigorous preparation, rapid response for detection and appropriate containment and treatment, with almost immediate access to PCR tests.

As the health service responds to the various backlogs that have developed as a result of the ongoing pandemic, Chris Hudson provides a brief overview of Roche digital solutions and how they facilitate better patient care.